Your browser doesn't support javascript.
loading
Persistence with long-term PCSK9 inhibitor treatment and its effectiveness in familial hypercholesterolaemia: data from the SAFEHEART study.
Alonso, Rodrigo; Arroyo-Olivares, Raquel; Muñiz-Grijalvo, Ovidio; Díaz-Díaz, Jose Luis; Muñoz-Torrero, Juan Sanchez; Romero, Manuel J; de Andrés, Raimundo; Zambón, Daniel; Mañas, María Dolores; Fuentes-Jiménez, Francisco; Aguado, Rocío; Alvarez-Baños, Pilar; Arrieta, Francisco; Gonzalez-Bustos, Pablo; Cepeda, José; Martin-Ordiales, Mercedes; Mosquera, Daniel; Michan, Alfredo; de Isla, Leopoldo Perez; Argueso, Rosa; Mata, Pedro.
Afiliación
  • Alonso R; Fundación Hipercolesterolemia Familiar, C/General Álvarez de Castro 14, 28010 Madrid, Spain.
  • Arroyo-Olivares R; Center for Advanced Metabolic Medicine and Nutrition, Santiago de Chile, Fundación hipercolesterolemia Familiar, Madrid, Spain.
  • Muñiz-Grijalvo O; Fundación Hipercolesterolemia Familiar, C/General Álvarez de Castro 14, 28010 Madrid, Spain.
  • Díaz-Díaz JL; Department of Internal Medicine, Hospital Virgen del Rocío, Sevilla, Spain.
  • Muñoz-Torrero JS; Department of Internal Medicine, Hospital Abente y Lago, A Coruña, Spain.
  • Romero MJ; Department of Internal Medicine, Hospital San Pedro de Alcántara, Cáceres, Spain.
  • de Andrés R; Department of Internal Medicine, Hospital Infanta Elena, Huelva, Spain.
  • Zambón D; Department of Internal Medicine, Fundación Jiménez Díaz, Madrid, Spain.
  • Mañas MD; Lipid Unit, Hospital Clinic, Barcelona, Spain.
  • Fuentes-Jiménez F; Department of Internal Medicine, Hospital Universitario, Ciudad Real, Spain.
  • Aguado R; Maimonides Biomedical Research Institute of Cordoba (IMIBIC), University of Cordoba, Reina Sofia University Hospital, CIBERObn, Córdoba, Spain.
  • Alvarez-Baños P; Department of Endocrinology, Hospital General de León, León, Spain.
  • Arrieta F; Department of Endocrinology, Hospital Universitario de Burgos, Burgos, Spain.
  • Gonzalez-Bustos P; Department of Endocrinology, Hospital Ramón y Cajal, Madrid, Spain.
  • Cepeda J; Department of Internal Medicine, Hospital Universitario Virgen de las Nieves, Granada, Spain.
  • Martin-Ordiales M; Department of Internal Medicine, Hospital Comarcal Vega Baja, Orihuela, Spain.
  • Mosquera D; Department of Internal Medicine, Hospital Universitario, Salamanca, Spain.
  • Michan A; Department of Internal Medicine, Hospital San Pedro, Logroño, Spain.
  • de Isla LP; Department of Internal Medicine, Hospital de Jerez, Jerez, Spain.
  • Argueso R; Department of Cardiology, Hospital Clínico San Carlos, IDISSC, Madrid, Spain.
  • Mata P; Department of Endocrinology, Hospital Universitario Lucus Augusti, Lugo, Spain.
Eur J Prev Cardiol ; 30(4): 320-328, 2023 03 01.
Article en En | MEDLINE | ID: mdl-36416136
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Inhibidores de Hidroximetilglutaril-CoA Reductasas / Hiperlipoproteinemia Tipo II / Anticolesterolemiantes Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: Eur J Prev Cardiol Año: 2023 Tipo del documento: Article País de afiliación: España
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Inhibidores de Hidroximetilglutaril-CoA Reductasas / Hiperlipoproteinemia Tipo II / Anticolesterolemiantes Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: Eur J Prev Cardiol Año: 2023 Tipo del documento: Article País de afiliación: España